Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Open Label, Clinical Trial to Assess Safety and Efficacy of Fexofenadine HCL + Pseudoephedrine HCL Fixed Dose Combination in Indian Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above (FAST Trial)

NCT05720455 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT05720455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05720455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Open Label, Clinical Trial to Assess Safety and Efficacy of Fexofenadine HCL + Pseudoephedrine HCL Fixed Dose Combination in Indian Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above (FAST Trial)
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
June 15, 2025
Completion date
December 5, 2025
Enrollment
203 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

rhinitis allergic